CervoMed Inc
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
CRVO$1.43+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
| ITEM 6. | EXHIBITS |
|---|
| Exhibit No. | Description | Method of Filing |
| 4.1 | Form of 2024 Private Placement Pre-Funded Warrant | Incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on March 28, 2024. |
| 4.2 | Form of 2024 Private Placement Series A Warrant | Incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on March 28, 2024. |
| 4.3 | Amendment to Pre-Funded Warrant, dated as of February 26, 2024, by and between CervoMed Inc. and the Joshua S. Boger 2021 Trust DTD 12/09/2021 | Incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on February 28, 2024. |
| 10.1 | Securities Purchase Agreement, dated March 28, 2024, by and between CervoMed Inc. and each of the purchasers party thereto | Incorporated by reference to Exhibit 10.19 to the Company’s Registration Statement on Form S-1 filed on May 10, 2024. |
| 10.2# | Amended & Restated Employment Agreement, dated as of February 1, 2024, by and between John Alam, M.D., and CervoMed Inc. | Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 2, 2024. |
| 10.3# | Amended & Restated Employment Agreement, dated as of February 1, 2024, by and between Robert J. Cobuzzi, Ph.D., and CervoMed Inc. | Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on February 2, 2024. |
| 10.4# | Employment Agreement, dated as of February 1, 2024, by and between Kelly Blackburn, M.H.A., and CervoMed Inc. | Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on February 2, 2024. |
| 31.1 | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) | Filed herewith. |
| 31.2 | Certification of the Acting Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) | Filed herewith. |
| 32.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) | Furnished herewith. |
| 32.2 | Certification of Acting Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) | Furnished herewith. |
| 101.INS* | Inline XBRL Instance Document | Filed herewith. |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | Filed herewith. |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith. |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith. |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed herewith. |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed herewith. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101) | Filed herewith. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.